AUTH/2005/5/07: GP v Pfizer – Celebrex journal ad claim ‘relieve my pain’ (No breach)

📅 2007 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2005/5/07
ComplainantGeneral practitioner
CompanyPfizer Limited
MedicineCelebrex (celecoxib)
MaterialJournal advertisement (COX459h), published in Geriatric Medicine, May 2007
Main issueAlleged exaggerated efficacy / implied guarantee of 100% pain relief from “I need a treatment that will relieve my pain” near efficacy claims
Clauses considered7.2, 7.4, 7.10
DecisionNo breach
Complaint received29 May 2007
Case completed6 July 2007
Applicable Code year2006
AppealNo appeal

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • A general practitioner complained about a Pfizer journal advertisement for Celebrex (celecoxib) published in Geriatric Medicine, May 2007 (ad code COX459h).
  • The complaint focused on the line “I need a treatment that will relieve my pain” placed close to efficacy claims, alleging it implied guaranteed 100% pain relief for all patients.
  • The PMCPA asked Pfizer to respond under Clauses 7.2, 7.4 and 7.10 (Code year 2006).
  • Pfizer argued the phrase was a patient aspiration and consistent with the licensed indication for “symptomatic relief” in OA, RA and ankylosing spondylitis, and that “relieve” does not imply 100% relief.
⚖️

Outcome

  • No breach of the Code was ruled.
  • No breach of Clauses 7.2, 7.4 and 7.10.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training